Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: IRWIN JAMES FRANKEL who wrote (5470)	1/18/2002 9:35:58 PM
From: Ian@SI	Respond to of 52153

What happened today to change the markets view of value? We have a congressional investigation. I do not think that materially changes the value of IMCL. On one of CNBC's IMCL discussions, it was stated that the House Panel investigation was at the request of the FDA; and that the FDA was concerned with statements made by IMCL which may inappropriately raise the hopes of Cancer patients. I've not seen any of these CNBC statements repeated elsewhere - in print or on TV. Thus it's difficult to accept them as gospel. On the other hand, if they're true, it would imply that IMCL still has substantial material, undisclosed information; and that their statements have seriously annoyed the FDA. I can't recall the FDA ever requesting a house panel to investigate a company!!!